-
1
-
-
84892805731
-
Cancer statistics
-
PID: 24399786
-
Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics. CA Cancer J Clin 64(1):9–29
-
(2014)
CA Cancer J Clin
, vol.64
, Issue.1
, pp. 9-29
-
-
Siegel, R.1
Ma, J.2
Zou, Z.3
Jemal, A.4
-
2
-
-
75749092296
-
Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen
-
COI: 1:CAS:528:DC%2BC3cXivFartbk%3D, PID: 19949017
-
Dowsett M, Cuzick J, Ingle J, Coates A, Forbes J, Bliss J, Buyse M, Baum M, Buzdar A, Colleoni M, Coombes C, Snowdon C, Gnant M, Jakesz R, Kaufmann M, Boccardo F, Godwin J, Davies C, Peto R (2010) Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol 28(3):509–518
-
(2010)
J Clin Oncol
, vol.28
, Issue.3
, pp. 509-518
-
-
Dowsett, M.1
Cuzick, J.2
Ingle, J.3
Coates, A.4
Forbes, J.5
Bliss, J.6
Buyse, M.7
Baum, M.8
Buzdar, A.9
Colleoni, M.10
Coombes, C.11
Snowdon, C.12
Gnant, M.13
Jakesz, R.14
Kaufmann, M.15
Boccardo, F.16
Godwin, J.17
Davies, C.18
Peto, R.19
-
3
-
-
23444446523
-
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years’ adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial
-
COI: 1:CAS:528:DC%2BD2MXntVeisLw%3D, PID: 16084253
-
Jakesz R, Jonat W, Gnant M, Mittlboeck M, Greil R, Tausch C, Hilfrich J, Kwasny W, Menzel C, Samonigg H, Seifert M, Gademann G, Kaufmann M, Wolfgang J (2005) Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years’ adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366(9484):455–462
-
(2005)
Lancet
, vol.366
, Issue.9484
, pp. 455-462
-
-
Jakesz, R.1
Jonat, W.2
Gnant, M.3
Mittlboeck, M.4
Greil, R.5
Tausch, C.6
Hilfrich, J.7
Kwasny, W.8
Menzel, C.9
Samonigg, H.10
Seifert, M.11
Gademann, G.12
Kaufmann, M.13
Wolfgang, J.14
-
4
-
-
69049113989
-
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer
-
COI: 1:CAS:528:DC%2BD1MXhtVWls7fM, PID: 19692688
-
Mouridsen H, Giobbie-Hurder A, Goldhirsch A, Thurlimann B, Paridaens R, Smith I, Mauriac L, Forbes J, Price KN, Regan MM, Gelber RD, Coates AS (2009) Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. N Engl J Med 361(8):766–776
-
(2009)
N Engl J Med
, vol.361
, Issue.8
, pp. 766-776
-
-
Mouridsen, H.1
Giobbie-Hurder, A.2
Goldhirsch, A.3
Thurlimann, B.4
Paridaens, R.5
Smith, I.6
Mauriac, L.7
Forbes, J.8
Price, K.N.9
Regan, M.M.10
Gelber, R.D.11
Coates, A.S.12
-
5
-
-
78649603622
-
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
-
COI: 1:CAS:528:DC%2BC3cXhsVyhsLnF, PID: 21087898
-
Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, Forbes JF (2010) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol 11(12):1135–1141
-
(2010)
Lancet Oncol
, vol.11
, Issue.12
, pp. 1135-1141
-
-
Cuzick, J.1
Sestak, I.2
Baum, M.3
Buzdar, A.4
Howell, A.5
Dowsett, M.6
Forbes, J.F.7
-
6
-
-
84921304485
-
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial
-
Cuzick J, Sestak I, Forbes JF, Dowsett M, Knox J, Cawthorn S, Saunders C, Roche N, Mansel RE, von Minckwitz G, Bonanni B, Palva T, Howell A (2014) Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial. Lancet 383(9922):1040
-
(2014)
Lancet
, vol.383
, Issue.9922
, pp. 1040
-
-
Cuzick, J.1
Sestak, I.2
Forbes, J.F.3
Dowsett, M.4
Knox, J.5
Cawthorn, S.6
Saunders, C.7
Roche, N.8
Mansel, R.E.9
von Minckwitz, G.10
Bonanni, B.11
Palva, T.12
Howell, A.13
-
7
-
-
0034892579
-
Adjuvant chemotherapy for breast cancer: an update
-
COI: 1:CAS:528:DC%2BD3MXms1Wju7Y%3D, PID: 11498830
-
Tan AR, Swain SM (2001) Adjuvant chemotherapy for breast cancer: an update. Semin Oncol 28(4):359–376
-
(2001)
Semin Oncol
, vol.28
, Issue.4
, pp. 359-376
-
-
Tan, A.R.1
Swain, S.M.2
-
8
-
-
84857236823
-
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
-
COI: 1:CAS:528:DC%2BC38XisFWjsrs%3D, PID: 22257673
-
Baselga J, Bradbury I, Eidtmann H, Di Cosimo S, de Azambuja E, Aura C, Gomez H, Dinh P, Fauria K, Van Dooren V, Aktan G, Goldhirsch A, Chang TW, Horvath Z, Coccia-Portugal M, Domont J, Tseng LM, Kunz G, Sohn JH, Semiglazov V, Lerzo G, Palacova M, Probachai V, Pusztai L, Untch M, Gelber RD, Piccart-Gebhart M, Neo AST (2012) Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial. Lancet 379(9816):633–640
-
(2012)
Lancet
, vol.379
, Issue.9816
, pp. 633-640
-
-
Baselga, J.1
Bradbury, I.2
Eidtmann, H.3
Di Cosimo, S.4
de Azambuja, E.5
Aura, C.6
Gomez, H.7
Dinh, P.8
Fauria, K.9
Van Dooren, V.10
Aktan, G.11
Goldhirsch, A.12
Chang, T.W.13
Horvath, Z.14
Coccia-Portugal, M.15
Domont, J.16
Tseng, L.M.17
Kunz, G.18
Sohn, J.H.19
Semiglazov, V.20
Lerzo, G.21
Palacova, M.22
Probachai, V.23
Pusztai, L.24
Untch, M.25
Gelber, R.D.26
Piccart-Gebhart, M.27
Neo, A.S.T.28
more..
-
9
-
-
33845886440
-
Lapatinib plus capecitabine for HER2-positive advanced breast cancer
-
COI: 1:CAS:528:DC%2BD2sXhslSqsA%3D%3D, PID: 17192538
-
Geyer CE, Forster J, Lindquist D, Chan S, Romieu CG, Pienkowski T, Jagiello-Gruszfeld A, Crown J, Chan A, Kaufman B, Skarlos D, Campone M, Davidson N, Berger M, Oliva C, Rubin SD, Stein S, Cameron D (2006) Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med 355(26):2733–2743
-
(2006)
N Engl J Med
, vol.355
, Issue.26
, pp. 2733-2743
-
-
Geyer, C.E.1
Forster, J.2
Lindquist, D.3
Chan, S.4
Romieu, C.G.5
Pienkowski, T.6
Jagiello-Gruszfeld, A.7
Crown, J.8
Chan, A.9
Kaufman, B.10
Skarlos, D.11
Campone, M.12
Davidson, N.13
Berger, M.14
Oliva, C.15
Rubin, S.D.16
Stein, S.17
Cameron, D.18
-
10
-
-
70350235064
-
Identification of novel kinase targets for the treatment of estrogen receptor-negative breast cancer
-
COI: 1:CAS:528:DC%2BD1MXhtlyqsLfK, PID: 19808870
-
Speers C, Tsimelzon A, Sexton K, Herrick AM, Gutierrez C, Culhane A, Quackenbush J, Hilsenbeck S, Chang J, Brown P (2009) Identification of novel kinase targets for the treatment of estrogen receptor-negative breast cancer. Clin Cancer Res 15(20):6327–6340
-
(2009)
Clin Cancer Res
, vol.15
, Issue.20
, pp. 6327-6340
-
-
Speers, C.1
Tsimelzon, A.2
Sexton, K.3
Herrick, A.M.4
Gutierrez, C.5
Culhane, A.6
Quackenbush, J.7
Hilsenbeck, S.8
Chang, J.9
Brown, P.10
-
11
-
-
0035100127
-
Inactivation of JNK activity by mitogen-activated protein kinase phosphatase-2 in EAhy926 endothelial cells is dependent upon agonist-specific JNK translocation to the nucleus
-
COI: 1:CAS:528:DC%2BD3MXitVOmtLk%3D, PID: 11257445
-
Robinson CJ, Sloss CM, Plevin R (2001) Inactivation of JNK activity by mitogen-activated protein kinase phosphatase-2 in EAhy926 endothelial cells is dependent upon agonist-specific JNK translocation to the nucleus. Cell Signal 13(1):29–41
-
(2001)
Cell Signal
, vol.13
, Issue.1
, pp. 29-41
-
-
Robinson, C.J.1
Sloss, C.M.2
Plevin, R.3
-
12
-
-
0029918680
-
The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation
-
COI: 1:CAS:528:DyaK28XhslGnsrs%3D, PID: 8626452
-
Chu Y, Solski PA, Khosravi-Far R, Der CJ, Kelly K (1996) The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J Biol Chem 271(11):6497–6501
-
(1996)
J Biol Chem
, vol.271
, Issue.11
, pp. 6497-6501
-
-
Chu, Y.1
Solski, P.A.2
Khosravi-Far, R.3
Der, C.J.4
Kelly, K.5
-
13
-
-
0035800855
-
Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MAP kinase phosphatase-2 and their ability to activate the phosphatase catalytically
-
COI: 1:CAS:528:DC%2BD3MXlvFSqtbw%3D, PID: 11387337
-
Chen P, Hutter D, Yang X, Gorospe M, Davis RJ, Liu Y (2001) Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MAP kinase phosphatase-2 and their ability to activate the phosphatase catalytically. J Biol Chem 276(31):29440–29449
-
(2001)
J Biol Chem
, vol.276
, Issue.31
, pp. 29440-29449
-
-
Chen, P.1
Hutter, D.2
Yang, X.3
Gorospe, M.4
Davis, R.J.5
Liu, Y.6
-
14
-
-
33947513279
-
Modulation of replicative senescence of diploid human cells by nuclear ERK signaling
-
COI: 1:CAS:528:DC%2BD2sXht1Ojtr8%3D, PID: 17145763
-
Tresini M, Lorenzini A, Torres C, Cristofalo VJ (2007) Modulation of replicative senescence of diploid human cells by nuclear ERK signaling. J Biol Chem 282(6):4136–4151
-
(2007)
J Biol Chem
, vol.282
, Issue.6
, pp. 4136-4151
-
-
Tresini, M.1
Lorenzini, A.2
Torres, C.3
Cristofalo, V.J.4
-
15
-
-
68349139723
-
An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors
-
COI: 1:CAS:528:DC%2BD1MXnt1Sht7c%3D, PID: 19525976
-
Chitale D, Gong Y, Taylor BS, Broderick S, Brennan C, Somwar R, Golas B, Wang L, Motoi N, Szoke J, Reinersman JM, Major J, Sander C, Seshan VE, Zakowski MF, Rusch V, Pao W, Gerald W, Ladanyi M (2009) An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors. Oncogene 28(31):2773–2783
-
(2009)
Oncogene
, vol.28
, Issue.31
, pp. 2773-2783
-
-
Chitale, D.1
Gong, Y.2
Taylor, B.S.3
Broderick, S.4
Brennan, C.5
Somwar, R.6
Golas, B.7
Wang, L.8
Motoi, N.9
Szoke, J.10
Reinersman, J.M.11
Major, J.12
Sander, C.13
Seshan, V.E.14
Zakowski, M.F.15
Rusch, V.16
Pao, W.17
Gerald, W.18
Ladanyi, M.19
-
16
-
-
84863726932
-
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance
-
COI: 1:CAS:528:DC%2BC38Xot1Chu70%3D, PID: 22683778
-
Balko JM, Cook RS, Vaught DB, Kuba MG, Miller TW, Bhola NE, Sanders ME, Granja-Ingram NM, Smith JJ, Meszoely IM, Salter J, Dowsett M, Stemke-Hale K, Gonzalez-Angulo AM, Mills GB, Pinto JA, Gomez HL, Arteaga CL (2012) Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance. Nat Med 18(7):1052–1059
-
(2012)
Nat Med
, vol.18
, Issue.7
, pp. 1052-1059
-
-
Balko, J.M.1
Cook, R.S.2
Vaught, D.B.3
Kuba, M.G.4
Miller, T.W.5
Bhola, N.E.6
Sanders, M.E.7
Granja-Ingram, N.M.8
Smith, J.J.9
Meszoely, I.M.10
Salter, J.11
Dowsett, M.12
Stemke-Hale, K.13
Gonzalez-Angulo, A.M.14
Mills, G.B.15
Pinto, J.A.16
Gomez, H.L.17
Arteaga, C.L.18
-
17
-
-
58149181363
-
Cell line data base: structure and recent improvements towards molecular authentication of human cell lines
-
COI: 1:CAS:528:DC%2BD1cXhsFejtLfP, PID: 18927105
-
Romano P, Manniello A, Aresu O, Armento M, Cesaro M, Parodi B (2009) Cell line data base: structure and recent improvements towards molecular authentication of human cell lines. Nucleic Acids Res 37:D925–D932
-
(2009)
Nucleic Acids Res
, vol.37
, pp. D925-D932
-
-
Romano, P.1
Manniello, A.2
Aresu, O.3
Armento, M.4
Cesaro, M.5
Parodi, B.6
-
18
-
-
84878552107
-
Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8
-
COI: 1:CAS:528:DC%2BC3sXosFSqt7Y%3D, PID: 23633491
-
Hartman ZC, Poage GM, den Hollander P, Tsimelzon A, Hill J, Panupinthu N, Zhang Y, Mazumdar A, Hilsenbeck SG, Mills GB, Brown PH (2013) Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8. Cancer Res 73(11):3470–3480
-
(2013)
Cancer Res
, vol.73
, Issue.11
, pp. 3470-3480
-
-
Hartman, Z.C.1
Poage, G.M.2
den Hollander, P.3
Tsimelzon, A.4
Hill, J.5
Panupinthu, N.6
Zhang, Y.7
Mazumdar, A.8
Hilsenbeck, S.G.9
Mills, G.B.10
Brown, P.H.11
-
19
-
-
71549116718
-
Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells
-
COI: 1:CAS:528:DC%2BD1MXhsV2itLrL, PID: 19920204
-
Chen L, Mayer JA, Krisko TI, Speers CW, Wang T, Hilsenbeck SG, Brown PH (2009) Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells. Cancer Res 69(23):8853–8861
-
(2009)
Cancer Res
, vol.69
, Issue.23
, pp. 8853-8861
-
-
Chen, L.1
Mayer, J.A.2
Krisko, T.I.3
Speers, C.W.4
Wang, T.5
Hilsenbeck, S.G.6
Brown, P.H.7
-
20
-
-
84875740314
-
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal
-
PID: 23550210
-
Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6(269):pl1
-
(2013)
Sci Signal
, vol.6
, Issue.269
, pp. pl1
-
-
Gao, J.1
Aksoy, B.A.2
Dogrusoz, U.3
Dresdner, G.4
Gross, B.5
Sumer, S.O.6
Sun, Y.7
Jacobsen, A.8
Sinha, R.9
Larsson, E.10
Cerami, E.11
Sander, C.12
Schultz, N.13
-
21
-
-
84866002291
-
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data
-
PID: 22588877
-
Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2(5):401–404
-
(2012)
Cancer Discov
, vol.2
, Issue.5
, pp. 401-404
-
-
Cerami, E.1
Gao, J.2
Dogrusoz, U.3
Gross, B.E.4
Sumer, S.O.5
Aksoy, B.A.6
Jacobsen, A.7
Byrne, C.J.8
Heuer, M.L.9
Larsson, E.10
Antipin, Y.11
Reva, B.12
Goldberg, A.P.13
Sander, C.14
Schultz, N.15
-
22
-
-
0037137519
-
A gene-expression signature as a predictor of survival in breast cancer
-
COI: 1:CAS:528:DC%2BD38Xps1Ojt7w%3D
-
VandeVijver MJ, He YD, van’t Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, vander Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347(25):1999–2009
-
(2002)
N Engl J Med
, vol.347
, Issue.25
, pp. 1999-2009
-
-
VandeVijver, M.J.1
He, Y.D.2
van’t Veer, L.J.3
Dai, H.4
Hart, A.A.5
Voskuil, D.W.6
Schreiber, G.J.7
Peterse, J.L.8
Roberts, C.9
Marton, M.J.10
Parrish, M.11
Atsma, D.12
Witteveen, A.13
Glas, A.14
Delahaye, L.15
vander Velde, T.16
Bartelink, H.17
Rodenhuis, S.18
Rutgers, E.T.19
Friend, S.H.20
Bernards, R.21
more..
-
23
-
-
34250652449
-
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
-
COI: 1:CAS:528:DC%2BD2sXmtVajur0%3D, PID: 17545524
-
Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, Haibe-Kains B, Viale G, Delorenzi M, Zhang Y, d’Assignies MS, Bergh J, Lidereau R, Ellis P, Harris AL, Klijn JG, Foekens JA, Cardoso F, Piccart MJ, Buyse M, Sotiriou C (2007) Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 13(11):3207–3214
-
(2007)
Clin Cancer Res
, vol.13
, Issue.11
, pp. 3207-3214
-
-
Desmedt, C.1
Piette, F.2
Loi, S.3
Wang, Y.4
Lallemand, F.5
Haibe-Kains, B.6
Viale, G.7
Delorenzi, M.8
Zhang, Y.9
d’Assignies, M.S.10
Bergh, J.11
Lidereau, R.12
Ellis, P.13
Harris, A.L.14
Klijn, J.G.15
Foekens, J.A.16
Cardoso, F.17
Piccart, M.J.18
Buyse, M.19
Sotiriou, C.20
more..
-
24
-
-
79955121426
-
Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization
-
PID: 21501481
-
Kao KJ, Chang KM, Hsu HC, Huang AT (2011) Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization. BMC Cancer 11:143
-
(2011)
BMC Cancer
, vol.11
, pp. 143
-
-
Kao, K.J.1
Chang, K.M.2
Hsu, H.C.3
Huang, A.T.4
-
25
-
-
33845191779
-
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
-
COI: 1:CAS:528:DC%2BD28XhtlCnsrbF, PID: 17157792
-
Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo WL, Lapuk A, Neve RM, Qian Z, Ryder T, Chen F, Feiler H, Tokuyasu T, Kingsley C, Dairkee S, Meng Z, Chew K, Pinkel D, Jain A, Ljung BM, Esserman L, Albertson DG, Waldman FM, Gray JW (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10(6):529–541
-
(2006)
Cancer Cell
, vol.10
, Issue.6
, pp. 529-541
-
-
Chin, K.1
DeVries, S.2
Fridlyand, J.3
Spellman, P.T.4
Roydasgupta, R.5
Kuo, W.L.6
Lapuk, A.7
Neve, R.M.8
Qian, Z.9
Ryder, T.10
Chen, F.11
Feiler, H.12
Tokuyasu, T.13
Kingsley, C.14
Dairkee, S.15
Meng, Z.16
Chew, K.17
Pinkel, D.18
Jain, A.19
Ljung, B.M.20
Esserman, L.21
Albertson, D.G.22
Waldman, F.M.23
Gray, J.W.24
more..
-
26
-
-
13844310310
-
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
-
COI: 1:CAS:528:DC%2BD2MXhsVOitLk%3D, PID: 15721472
-
Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu J, Jatkoe T, Berns EM, Atkins D, Foekens JA (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365(9460):671–679
-
(2005)
Lancet
, vol.365
, Issue.9460
, pp. 671-679
-
-
Wang, Y.1
Klijn, J.G.2
Zhang, Y.3
Sieuwerts, A.M.4
Look, M.P.5
Yang, F.6
Talantov, D.7
Timmermans, M.8
Meijer-van Gelder, M.E.9
Yu, J.10
Jatkoe, T.11
Berns, E.M.12
Atkins, D.13
Foekens, J.A.14
-
27
-
-
23144461051
-
Genes that mediate breast cancer metastasis to lung
-
COI: 1:CAS:528:DC%2BD2MXmsFCgs7o%3D, PID: 16049480
-
Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J (2005) Genes that mediate breast cancer metastasis to lung. Nature 436(7050):518–524
-
(2005)
Nature
, vol.436
, Issue.7050
, pp. 518-524
-
-
Minn, A.J.1
Gupta, G.P.2
Siegel, P.M.3
Bos, P.D.4
Shu, W.5
Giri, D.D.6
Viale, A.7
Olshen, A.B.8
Gerald, W.L.9
Massague, J.10
-
28
-
-
34250687198
-
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
-
COI: 1:CAS:528:DC%2BD2sXlslWqtLw%3D, PID: 17452630
-
Saal LH, Johansson P, Holm K, Gruvberger-Saal SK, She QB, Maurer M, Koujak S, Ferrando AA, Malmstrom P, Memeo L, Isola J, Bendahl PO, Rosen N, Hibshoosh H, Ringner M, Borg A, Parsons R (2007) Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity. Proc Natl Acad Sci USA 104(18):7564–7569
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, Issue.18
, pp. 7564-7569
-
-
Saal, L.H.1
Johansson, P.2
Holm, K.3
Gruvberger-Saal, S.K.4
She, Q.B.5
Maurer, M.6
Koujak, S.7
Ferrando, A.A.8
Malmstrom, P.9
Memeo, L.10
Isola, J.11
Bendahl, P.O.12
Rosen, N.13
Hibshoosh, H.14
Ringner, M.15
Borg, A.16
Parsons, R.17
-
29
-
-
84861527388
-
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
-
COI: 1:CAS:528:DC%2BC38XlslSnsL8%3D, PID: 22522925
-
Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Graf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, Group M, Langerod A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, Borresen-Dale AL, Brenton JD, Tavare S, Caldas C, Caldas C, Aparicio S (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486(7403):346–352
-
(2012)
Nature
, vol.486
, Issue.7403
, pp. 346-352
-
-
Curtis, C.1
Shah, S.P.2
Chin, S.F.3
Turashvili, G.4
Rueda, O.M.5
Dunning, M.J.6
Speed, D.7
Lynch, A.G.8
Samarajiwa, S.9
Yuan, Y.10
Graf, S.11
Ha, G.12
Haffari, G.13
Bashashati, A.14
Russell, R.15
McKinney, S.16
Group, M.17
Langerod, A.18
Green, A.19
Provenzano, E.20
Wishart, G.21
Pinder, S.22
Watson, P.23
Markowetz, F.24
Murphy, L.25
Ellis, I.26
Purushotham, A.27
Borresen-Dale, A.L.28
Brenton, J.D.29
Tavare, S.30
Caldas, C.31
Caldas, C.32
Aparicio, S.33
more..
-
30
-
-
39749176127
-
Predicting features of breast cancer with gene expression patterns
-
COI: 1:CAS:528:DC%2BD1cXitleqsb0%3D, PID: 18297396
-
Lu X, Lu X, Wang ZC, Iglehart JD, Zhang X, Richardson AL (2008) Predicting features of breast cancer with gene expression patterns. Breast Cancer Res Treat 108(2):191–201
-
(2008)
Breast Cancer Res Treat
, vol.108
, Issue.2
, pp. 191-201
-
-
Lu, X.1
Lu, X.2
Wang, Z.C.3
Iglehart, J.D.4
Zhang, X.5
Richardson, A.L.6
-
31
-
-
79955798310
-
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer
-
COI: 1:CAS:528:DC%2BC3MXlvFKisLg%3D, PID: 21558518
-
Hatzis C, Pusztai L, Valero V, Booser DJ, Esserman L, Lluch A, Vidaurre T, Holmes F, Souchon E, Wang H, Martin M, Cotrina J, Gomez H, Hubbard R, Chacon JI, Ferrer-Lozano J, Dyer R, Buxton M, Gong Y, Wu Y, Ibrahim N, Andreopoulou E, Ueno NT, Hunt K, Yang W, Nazario A, DeMichele A, O’Shaughnessy J, Hortobagyi GN, Symmans WF (2011) A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA 305(18):1873–1881
-
(2011)
JAMA
, vol.305
, Issue.18
, pp. 1873-1881
-
-
Hatzis, C.1
Pusztai, L.2
Valero, V.3
Booser, D.J.4
Esserman, L.5
Lluch, A.6
Vidaurre, T.7
Holmes, F.8
Souchon, E.9
Wang, H.10
Martin, M.11
Cotrina, J.12
Gomez, H.13
Hubbard, R.14
Chacon, J.I.15
Ferrer-Lozano, J.16
Dyer, R.17
Buxton, M.18
Gong, Y.19
Wu, Y.20
Ibrahim, N.21
Andreopoulou, E.22
Ueno, N.T.23
Hunt, K.24
Yang, W.25
Nazario, A.26
DeMichele, A.27
O’Shaughnessy, J.28
Hortobagyi, G.N.29
Symmans, W.F.30
more..
-
32
-
-
34047174559
-
A module of negative feedback regulators defines growth factor signaling
-
COI: 1:CAS:528:DC%2BD2sXjsV2hsrs%3D, PID: 17322878
-
Amit I, Citri A, Shay T, Lu Y, Katz M, Zhang F, Tarcic G, Siwak D, Lahad J, Jacob-Hirsch J, Amariglio N, Vaisman N, Segal E, Rechavi G, Alon U, Mills GB, Domany E, Yarden Y (2007) A module of negative feedback regulators defines growth factor signaling. Nat Genet 39(4):503–512
-
(2007)
Nat Genet
, vol.39
, Issue.4
, pp. 503-512
-
-
Amit, I.1
Citri, A.2
Shay, T.3
Lu, Y.4
Katz, M.5
Zhang, F.6
Tarcic, G.7
Siwak, D.8
Lahad, J.9
Jacob-Hirsch, J.10
Amariglio, N.11
Vaisman, N.12
Segal, E.13
Rechavi, G.14
Alon, U.15
Mills, G.B.16
Domany, E.17
Yarden, Y.18
-
33
-
-
0031058730
-
Mitogen-activated protein kinase phosphatases inactivate stress-activated protein kinase pathways in vivo
-
COI: 1:CAS:528:DyaK2sXht1yltr4%3D, PID: 9020184
-
Hirsch DD, Stork PJ (1997) Mitogen-activated protein kinase phosphatases inactivate stress-activated protein kinase pathways in vivo. J Biol Chem 272(7):4568–4575
-
(1997)
J Biol Chem
, vol.272
, Issue.7
, pp. 4568-4575
-
-
Hirsch, D.D.1
Stork, P.J.2
-
34
-
-
3343026531
-
Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers
-
COI: 1:CAS:528:DC%2BD2cXlvVehsLw%3D, PID: 15184884
-
Armes JE, Hammet F, de Silva M, Ciciulla J, Ramus SJ, Soo WK, Mahoney A, Yarovaya N, Henderson MA, Gish K, Hutchins AM, Price GR, Venter DJ (2004) Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers. Oncogene 23(33):5697–5702
-
(2004)
Oncogene
, vol.23
, Issue.33
, pp. 5697-5702
-
-
Armes, J.E.1
Hammet, F.2
de Silva, M.3
Ciciulla, J.4
Ramus, S.J.5
Soo, W.K.6
Mahoney, A.7
Yarovaya, N.8
Henderson, M.A.9
Gish, K.10
Hutchins, A.M.11
Price, G.R.12
Venter, D.J.13
-
35
-
-
0029134795
-
Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q
-
COI: 1:CAS:528:DyaK2MXnt1antrw%3D, PID: 7614479
-
Radford DM, Fair KL, Phillips NJ, Ritter JH, Steinbrueck T, Holt MS, Donis-Keller H (1995) Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. Cancer Res 55(15):3399–3405
-
(1995)
Cancer Res
, vol.55
, Issue.15
, pp. 3399-3405
-
-
Radford, D.M.1
Fair, K.L.2
Phillips, N.J.3
Ritter, J.H.4
Steinbrueck, T.5
Holt, M.S.6
Donis-Keller, H.7
-
36
-
-
0036320867
-
Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization
-
COI: 1:CAS:528:DC%2BD38Xms1Sis7o%3D, PID: 12152162
-
Thor AD, Eng C, Devries S, Paterakos M, Watkin WG, Edgerton S, Moore DH 2nd, Etzell J, Waldman FM (2002) Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization. Hum Pathol 33(6):628–631
-
(2002)
Hum Pathol
, vol.33
, Issue.6
, pp. 628-631
-
-
Thor, A.D.1
Eng, C.2
Devries, S.3
Paterakos, M.4
Watkin, W.G.5
Edgerton, S.6
Moore, D.H.7
Etzell, J.8
Waldman, F.M.9
-
37
-
-
0032917458
-
Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1
-
COI: 1:CAS:528:DyaK1MXhtFGgtL8%3D, PID: 10023714
-
Yokota T, Yoshimoto M, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y, Emi M (1999) Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1. Cancer 85(2):447–452
-
(1999)
Cancer
, vol.85
, Issue.2
, pp. 447-452
-
-
Yokota, T.1
Yoshimoto, M.2
Akiyama, F.3
Sakamoto, G.4
Kasumi, F.5
Nakamura, Y.6
Emi, M.7
-
38
-
-
17644368572
-
Infrequent mutation of TRAIL receptor 2 (TRAIL-R2/DR5) in transitional cell carcinoma of the bladder with 8p21 loss of heterozygosity
-
COI: 1:CAS:528:DC%2BD2MXit1Cis74%3D, PID: 15766588
-
Adams J, Cuthbert-Heavens D, Bass S, Knowles MA (2005) Infrequent mutation of TRAIL receptor 2 (TRAIL-R2/DR5) in transitional cell carcinoma of the bladder with 8p21 loss of heterozygosity. Cancer Lett 220(2):137–144
-
(2005)
Cancer Lett
, vol.220
, Issue.2
, pp. 137-144
-
-
Adams, J.1
Cuthbert-Heavens, D.2
Bass, S.3
Knowles, M.A.4
-
39
-
-
70449732108
-
Deregulation of DUSP activity in EGFR-mutant lung cancer cell lines contributes to sustained ERK1/2 signaling
-
COI: 1:CAS:528:DC%2BD1MXhsVKgurzN, PID: 19836351
-
Britson JS, Barton F, Balko JM, Black EP (2009) Deregulation of DUSP activity in EGFR-mutant lung cancer cell lines contributes to sustained ERK1/2 signaling. Biochem Biophys Res Commun 390(3):849–854
-
(2009)
Biochem Biophys Res Commun
, vol.390
, Issue.3
, pp. 849-854
-
-
Britson, J.S.1
Barton, F.2
Balko, J.M.3
Black, E.P.4
-
40
-
-
76749139471
-
Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells
-
COI: 1:CAS:528:DC%2BC3cXhvFaktrk%3D, PID: 20124482
-
Waha A, Felsberg J, Hartmann W, von dem Knesebeck A, Mikeska T, Joos S, Wolter M, Koch A, Yan PS, Endl E, Wiestler OD, Reifenberger G, Pietsch T (2010) Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells. Cancer Res 70(4):1689–1699
-
(2010)
Cancer Res
, vol.70
, Issue.4
, pp. 1689-1699
-
-
Waha, A.1
Felsberg, J.2
Hartmann, W.3
von dem Knesebeck, A.4
Mikeska, T.5
Joos, S.6
Wolter, M.7
Koch, A.8
Yan, P.S.9
Endl, E.10
Wiestler, O.D.11
Reifenberger, G.12
Pietsch, T.13
-
41
-
-
21344444336
-
Complex CGH alterations on chromosome arm 8p at candidate tumor suppressor gene loci in breast cancer cell lines
-
COI: 1:CAS:528:DC%2BD2MXlvVWgu7c%3D, PID: 15993269
-
Venter DJ, Ramus SJ, Hammet FM, de Silva M, Hutchins AM, Petrovic V, Price G, Armes JE (2005) Complex CGH alterations on chromosome arm 8p at candidate tumor suppressor gene loci in breast cancer cell lines. Cancer Genet Cytogenet 160(2):134–140
-
(2005)
Cancer Genet Cytogenet
, vol.160
, Issue.2
, pp. 134-140
-
-
Venter, D.J.1
Ramus, S.J.2
Hammet, F.M.3
de Silva, M.4
Hutchins, A.M.5
Petrovic, V.6
Price, G.7
Armes, J.E.8
-
42
-
-
84886046699
-
Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer
-
COI: 1:CAS:528:DC%2BC3sXhs1ahur%2FL, PID: 23966295
-
Balko JM, Schwarz LJ, Bhola NE, Kurupi R, Owens P, Miller TW, Gomez H, Cook RS, Arteaga CL (2013) Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer. Cancer Res 73(20):6346–6358
-
(2013)
Cancer Res
, vol.73
, Issue.20
, pp. 6346-6358
-
-
Balko, J.M.1
Schwarz, L.J.2
Bhola, N.E.3
Kurupi, R.4
Owens, P.5
Miller, T.W.6
Gomez, H.7
Cook, R.S.8
Arteaga, C.L.9
-
43
-
-
0033970533
-
Dual specificity phosphatases: a gene family for control of MAP kinase function
-
COI: 1:CAS:528:DC%2BD3cXltFKgtA%3D%3D, PID: 10627275
-
Camps M, Nichols A, Arkinstall S (2000) Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J 14(1):6–16
-
(2000)
FASEB J
, vol.14
, Issue.1
, pp. 6-16
-
-
Camps, M.1
Nichols, A.2
Arkinstall, S.3
-
44
-
-
0035799557
-
Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase
-
COI: 1:CAS:528:DC%2BD3MXjsFGlsro%3D, PID: 11333986
-
Bulavin DV, Higashimoto Y, Popoff IJ, Gaarde WA, Basrur V, Potapova O, Appella E, Fornace AJ Jr (2001) Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 411(6833):102–107
-
(2001)
Nature
, vol.411
, Issue.6833
, pp. 102-107
-
-
Bulavin, D.V.1
Higashimoto, Y.2
Popoff, I.J.3
Gaarde, W.A.4
Basrur, V.5
Potapova, O.6
Appella, E.7
Fornace, A.J.8
-
45
-
-
17844398046
-
Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase
-
COI: 1:CAS:528:DC%2BD2MXjvVyktL8%3D, PID: 15753463
-
Gutierrez MC, Detre S, Johnston S, Mohsin SK, Shou J, Allred DC, Schiff R, Osborne CK, Dowsett M (2005) Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase. J Clin Oncol 23(11):2469–2476
-
(2005)
J Clin Oncol
, vol.23
, Issue.11
, pp. 2469-2476
-
-
Gutierrez, M.C.1
Detre, S.2
Johnston, S.3
Mohsin, S.K.4
Shou, J.5
Allred, D.C.6
Schiff, R.7
Osborne, C.K.8
Dowsett, M.9
-
46
-
-
33645730357
-
Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors
-
COI: 1:CAS:528:DC%2BD28XjtVOqs74%3D, PID: 16585219
-
Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D (2006) Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors. Cancer Res 66(7):3903–3911
-
(2006)
Cancer Res
, vol.66
, Issue.7
, pp. 3903-3911
-
-
Creighton, C.J.1
Hilger, A.M.2
Murthy, S.3
Rae, J.M.4
Chinnaiyan, A.M.5
El-Ashry, D.6
-
47
-
-
84991491983
-
Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients
-
COI: 1:CAS:528:DC%2BC2cXhsl2hsb3F, PID: 24861485
-
Takane K, Midorikawa Y, Yagi K, Sakai A, Aburatani H, Takayama T, Kaneda A (2014) Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients. Cancer Med 3(5):1235–1245
-
(2014)
Cancer Med
, vol.3
, Issue.5
, pp. 1235-1245
-
-
Takane, K.1
Midorikawa, Y.2
Yagi, K.3
Sakai, A.4
Aburatani, H.5
Takayama, T.6
Kaneda, A.7
-
48
-
-
58049188918
-
Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma
-
COI: 1:CAS:528:DC%2BD1cXhsFSnsbvJ, PID: 18803327
-
Bonazzi VF, Irwin D, Hayward NK (2009) Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma. Genes Chromosomes Cancer 48(1):10–21
-
(2009)
Genes Chromosomes Cancer
, vol.48
, Issue.1
, pp. 10-21
-
-
Bonazzi, V.F.1
Irwin, D.2
Hayward, N.K.3
-
49
-
-
67651148274
-
Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3 K signaling
-
COI: 1:CAS:528:DC%2BD1MXhsVCjsrfL, PID: 19647222
-
Gewinner C, Wang ZC, Richardson A, Teruya-Feldstein J, Etemadmoghadam D, Bowtell D, Barretina J, Lin WM, Rameh L, Salmena L, Pandolfi PP, Cantley LC (2009) Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3 K signaling. Cancer Cell 16(2):115–125
-
(2009)
Cancer Cell
, vol.16
, Issue.2
, pp. 115-125
-
-
Gewinner, C.1
Wang, Z.C.2
Richardson, A.3
Teruya-Feldstein, J.4
Etemadmoghadam, D.5
Bowtell, D.6
Barretina, J.7
Lin, W.M.8
Rameh, L.9
Salmena, L.10
Pandolfi, P.P.11
Cantley, L.C.12
-
50
-
-
33947529520
-
Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers
-
COI: 1:CAS:528:DC%2BD2sXjtlWgt78%3D, PID: 17001317
-
Chin SF, Wang Y, Thorne NP, Teschendorff AE, Pinder SE, Vias M, Naderi A, Roberts I, Barbosa-Morais NL, Garcia MJ, Iyer NG, Kranjac T, Robertson JF, Aparicio S, Tavare S, Ellis I, Brenton JD, Caldas C (2007) Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers. Oncogene 26(13):1959–1970
-
(2007)
Oncogene
, vol.26
, Issue.13
, pp. 1959-1970
-
-
Chin, S.F.1
Wang, Y.2
Thorne, N.P.3
Teschendorff, A.E.4
Pinder, S.E.5
Vias, M.6
Naderi, A.7
Roberts, I.8
Barbosa-Morais, N.L.9
Garcia, M.J.10
Iyer, N.G.11
Kranjac, T.12
Robertson, J.F.13
Aparicio, S.14
Tavare, S.15
Ellis, I.16
Brenton, J.D.17
Caldas, C.18
-
51
-
-
34447650761
-
High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization
-
COI: 1:CAS:528:DC%2BD28XitlGqs74%3D, PID: 16457699
-
Naylor TL, Greshock J, Wang Y, Colligon T, Yu QC, Clemmer V, Zaks TZ, Weber BL (2005) High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Res 7(6):R1186–R1198
-
(2005)
Breast Cancer Res
, vol.7
, Issue.6
, pp. R1186-R1198
-
-
Naylor, T.L.1
Greshock, J.2
Wang, Y.3
Colligon, T.4
Yu, Q.C.5
Clemmer, V.6
Zaks, T.Z.7
Weber, B.L.8
-
52
-
-
84876434755
-
Loss of FBP1 by snail-mediated repression provides metabolic advantages in basal-like breast cancer
-
COI: 1:CAS:528:DC%2BC3sXjtl2jtrs%3D, PID: 23453623
-
Dong C, Yuan T, Wu Y, Wang Y, Fan TW, Miriyala S, Lin Y, Yao J, Shi J, Kang T, Lorkiewicz P, St Clair D, Hung MC, Evers BM, Zhou BP (2013) Loss of FBP1 by snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell 23(3):316–331
-
(2013)
Cancer Cell
, vol.23
, Issue.3
, pp. 316-331
-
-
Dong, C.1
Yuan, T.2
Wu, Y.3
Wang, Y.4
Fan, T.W.5
Miriyala, S.6
Lin, Y.7
Yao, J.8
Shi, J.9
Kang, T.10
Lorkiewicz, P.11
St Clair, D.12
Hung, M.C.13
Evers, B.M.14
Zhou, B.P.15
|